Dictaphone Pen

Digital Pen Market Size, Share Trends Analysis & Research Report, 2031

www.mordorintelligence.com

The digital pen market size was valued at USD 3.35 billion in 2025 and estimated to grow from USD 3.81 billion in 2026 to reach USD 7.19 billion by 2031, at a CAGR of 13.57% during the forecast period (2026-2031). Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026. The digital pen market is valued at USD 3.81 billion in 2026 and is projected to reach USD 7.19 billion by 2031. April 2024: Anoto Group AB unveiled the inq line of smartpens, notebooks, and software, positioning the brand at the intersection of traditional ink feel and digital capture.

Insulin Pens Market Size, Analysis | Share & Global Report 2026 - 2031

www.mordorintelligence.com

External studies place the 2024 market at USD 9.60 billion and USD 7.79 billion, while an association lists USD 9.90 billion for 2022 and Mordor Intelligence arrives at USD 8.39 billion for 2025. ... By anchoring numbers to traceable patient counts and refreshed price curves, our baseline offers the most reproducible and balanced view for strategic planning. ... The insulin pens market stands at USD 9.09 billion in 2026 and is projected to reach USD 13.55 billion by 2031, expanding at a CAGR of 8.33% during 2026-2031. North America holds the largest share at 41.02%, while Asia-Pacific registers the fastest growth with a 9.52% CAGR through 2031. Who are the key players in the insulin pens market? Novo Nordisk, Eli Lilly, and Sanofi together control about 70% of global revenue, with Medtronic and BD leading in smart-pen platform partnerships. What major FDA approvals have shaped the market recently? Key clearances include Merilog biosimilar insulin in 2025 and expanded automated insulin dosing indications for type 2 diabetes in 2024. Supply tightness, visible through Tresiba FlexTouch shortages that persist until January 2026, has nudged prescribers toward reusable and smart alternatives. In parallel, the diabetes population is projected to rise from 529 million in 2021 to 1.31 billion by 2050, a trend that hardwires structural volume growth into the insulin pens market[1]Centers for Disease Control and Prevention, “National Diabetes Statistics Report 2023,” CDC, cdc.gov. The insulin pens market is moderately consolidated. Novo Nordisk, Eli Lilly, and Sanofi held roughly 70% combined share in 2024, leaning on proprietary insulin analog portfolios and high-volume manufacturing campuses that deliver scale advantages. Their depth in endocrine sales forces and formulary negotiating clout yields stickiness at both physician and payer levels.

Pen Needles Market Size, Growth Analysis & Industry Report, 2031

www.mordorintelligence.com

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026. ... Type 1 diagnoses in the United States climbed to 2.07 million in 2024 and are projected to reach 2.29 million by 2033, extending lifetime demand for injectable therapies [2]Rebecca Smith, “Prevalence Trends in Type 1 Diabetes,” Journal of Health Economics and Outcomes Research, jheor.org . The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value in USD for the above segments. ... The pen needles market size stood at USD 2.41 billion in 2026 and is projected to reach USD 3.68 billion by 2031. Surging obesity rates reinforce this trend because pharmacologic weight-loss regimens rely on the same subcutaneous delivery mechanisms used for insulin. Brazil alone recorded sales exceeding BRL 3 billion (USD 589 million) of GLP-1 drugs between September 2023 and September 2024, underscoring how non-diabetes indications now fuel incremental needle demand. The United States FDA issued a Class 2 recall of one BD Nano batch in 2024 over labeling irregularities, highlighting the intensified regulatory oversight that favors certified safety designs. Many procurement contracts now stipulate integrated shields, ensuring repeat orders once conversions occur. Embecta capitalized on these trends when Meridian Health added its safety line to an exclusive Medicaid formulary that took effect in August 2025.

Dicing Equipment Market - Companies, Size & Share

www.mordorintelligence.com

The combined 2025-2026 capital budgets of TSMC, SK Hynix, and Micron exceed USD 90 billion, with large allocations toward high-bandwidth memory and 2 nm logic nodes that each require 3-4 additional dicers per incremental 10 k-wpm capacity. Equipment pull-ins concentrate in Taiwan and South Korea, but pilot discussions with Gulf investors suggest a 5-7% re-routing of orders once export-control clearances emerge. Asia-Pacific accounted for 56.57% of 2025 revenue, and within the region, Taiwan, South Korea, and China remain the linchpins. Construction of SK Hynix’s M15X line and Yongin mega-fab will add more than 400 k-wpm of high-bandwidth memory capacity between 2026-2027, each requiring three to four dicers per 10 k-wpm tranche. The Dicing Equipment Market size is projected to be USD 0.82 billion in 2025, USD 0.88 billion in 2026, and reach USD 1.20 billion by 2031, growing at a CAGR of 6.33% from 2026 to 2031. By application, memory and logic produced 37.21% of 2025 revenue, and power devices are expected to expand at a 7.41% CAGR over 2026-2031.

Graphics Tablet Market Size, Trends And Forecast, Share Analysis 2031

www.mordorintelligence.com

The Graphics Tablet Market worth USD 0.76 billion in 2026 is growing at a CAGR of 12.02% to reach USD 1.34 billion by 2031. Wacom Co., Ltd., XP-Pen Technology Co., Ltd., Shenzhen Ugee Technology Co., Ltd., Shenzhen Huion Animation Technology Co., Ltd. and Artisul are the major companies operating in this market. The graphics tablet market size was valued at USD 0.68 billion in 2025 and estimated to grow from USD 0.76 billion in 2026 to reach USD 1.34 billion by 2031, at a CAGR of 12.02% during the forecast period (2026-2031). Robust growth stems from the mainstreaming of digital-first content workflows, the expansion of remote learning, and continuous improvements in stylus technology that narrow the gap between analog and digital creation. Falling average selling prices (ASPs) for entry-level devices continue to broaden the user base, while premium pen displays enjoy steady demand from professional and enterprise buyers seeking high-precision input. Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026. The graphics tablet market is worth USD 0.76 billion in 2026 and is projected to reach USD 1.34 billion by 2031.

Pharmaceutical Cartridges Market Size, Growth Report 2026 – 2031

www.mordorintelligence.com

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026. ... Pen injectors and wearable pumps now anchor patient-centred treatment, letting individuals administer chronic therapies without clinic visits. Ypsomed sold over 12 million reusable pens and 1.7 billion prefilled pens in 2024, underscoring adoption scale. The Pharmaceutical Cartridges Market Report is Segmented by Material (Glass [Type I and More], Engineering Plastics [COP/COC and More] and More), Delivery Device Compatibility (Reusable Pen Injectors, Autoinjectors and More), Capacity (<3ml, 3ml-5ml, and More), Therapeutic Area (Ophthalmology and More), End User (Pharmaceutical Companies, and More), and Geography. The Market Forecasts are Provided in Terms of Value (USD). ... Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. The pharmaceutical cartridge market size is expected to grow from USD 1.86 billion in 2025 to USD 2.01 billion in 2026 and is forecast to reach USD 2.92 billion by 2031 at 7.80% CAGR over 2026-2031. By delivery-device compatibility, reusable pen injectors led with 43.55% revenue share in 2025; wearable on-body pumps are expected to scale at an 10.98% CAGR to 2031. By capacity, cartridges below 3 mL accounted for 40.92% of pharmaceutical cartridge market size in 2025, whereas devices above 10 mL are projected to grow at a 9.86% CAGR during 2026-2031. As RTU offerings expand, more of the complexity shifts upstream to container suppliers that deliver pre-washed, depyrogenated, and sterile nests or tubs, allowing drug manufacturers and CDMOs to concentrate on aseptic filling, stoppering, inspection, and device assembly for pens, autoinjectors, and wearable systems. Across the chain, qualification burden and change control are key governance points, since any material, process, or supplier change typically requires re-qualification with the drug sponsor under cGMP expectations and quality agreements. In 2026, West Pharmaceutical Services highlighted this balancing act through collaboration and portfolio reallocation: it renewed its technology exchange and cross-licensing agreement with Daikyo Seiko, Ltd.